WORKSHOP: The Science of ECP in Transplantation (German)

Around 25% of organ transplant recipients encounter acute rejection within the first year post-transplantation. Acute rejection is further categorised into cellular (ACR) and antibody-mediated (AMR) forms. Over the long term, the threat shifts to chronic rejection, which poses a significant risk to graft function and patient survival.

Finding a balance between the beneficial and adverse effects of immunosuppression in preventing or treating rejection remains challenging. Factors such as opportunistic infections and malignancies further complicate this issue. Consequently, there is a keen interest in therapies that can effectively modulate alloimmune responses without suppressing the immune system’s ability to fight infection or malignancy.

Extracorporeal Photopheresis (ECP) presents a potential approach to achieving this balance in organ transplantation, although its precise mechanism of action has yet to be fully determined.

Programme (in German):

• Einleitung – Markus J. Barten
• Akute Abstoßung nach Herztransplantation: Erfahrungen eines Patienten  – Marc Kritzky 
• Erfahrung aus Hannover: wer profitiert von der ECP nach Lungentransplantation  – Mark Greer 
• Personalisierte Therapie mit ECP in Patienten nach Herztransplantation – Markus J. Barten
• Fragen&Antworten  – Experten 
• Zusammenfassung und Verabschiedung – Markus J. Barten

Please fill out the Workshop Registration to get an email for your direct access link.

DISCLAIMER: This workshop is possible thanks to the unrestricted grant support from

 Physicians, Scientists, Allied Health Care Professionals, Nurses, Patients